Rockefeller Capital Management
PAHC icon

Rockefeller Capital Management’s Phibro Animal Health PAHC Stock Holding History

Rockefeller Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.2K Hold
396
– – ﹤0.01% 4025
2026
Q2 		$12.4K Sell
396
-8
-2% -$338 ﹤0.01% 3921
2026
Q1 		$22.3K Buy
404
+296
+274% +$14.1K ﹤0.01% 3671
2025
Q4 		$4.04K Sell
108
-4
-4% -$162 ﹤0.01% 4138
2025
Q3 		$4.53K Buy
+112
New +$3.7K ﹤0.01% 3896
2023
Q1 		– Sell
-2,494
Closed -$32K – 3314
2022
Q4 		$32K Buy
2,494
+2,484
+24,840% +$33.3K ﹤0.01% 2600
2022
Q3 		$0 Sell
10
-386
-97% -$6.66K ﹤0.01% 4252
2022
Q2 		$7K Buy
396
+380
+2,375% +$7.2K ﹤0.01% 3315
2022
Q1 		$0 Hold
16
– – ﹤0.01% 4020
2021
Q4 		$0 Hold
16
– – ﹤0.01% 3936
2021
Q3 		$0 Buy
+16
New +$385 ﹤0.01% 3803
2020
Q3 		– Sell
-26
Closed -$1K – 2733
2020
Q2 		$1K Buy
+26
New +$646 ﹤0.01% 2482

Other funds holding PAHC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Rockefeller Capital Management's PAHC Position: Q3 2026 in Review

Rockefeller Capital Management held its Phibro Animal Health (PAHC) position steady in Q3 2026 at 396 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4025.

Rockefeller Capital Management first reported a position in PAHC in Q2 2020 and has held it in 12 quarters since. The position peaked at $32K in Q4 2022. 181 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

  • Rockefeller Capital Management held 396 shares of Phibro Animal Health worth $14.2K as of Q3 2026.
  • Rockefeller Capital Management left its Phibro Animal Health share count unchanged in Q3 2026.
  • Phibro Animal Health made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4025 holding.
  • Rockefeller Capital Management first reported a position in Phibro Animal Health in Q2 2020 and has held it in 12 quarters since.
  • Rockefeller Capital Management's Phibro Animal Health position peaked at $32K in Q4 2022.
  • 181 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.